Results 71 to 80 of about 90,057,531 (289)

Changes in essential cancer medicines and association with cancer outcomes: an observational study of 158 countries

BMC Cancer
Background Cancer is a major cause of mortality worldwide, and differences in cancer mortality rates between countries are, in part, due to differences in access to cancer care, including medicines.
Moizza Zia Ul Haq, Camila Heredia, Adelaide Buadu, Amal Rizvi, Aine Workentin, Nav Persaud   +5 more
doaj   +1 more source

Judicial litigations and social welfare: access to medicines in two towns in the Santa Catarina State, Brazil - 10.4025/actascihealthsci.v34ispec.10084

Acta Scientiarum. Health Sciences, 2012
The growing number of lawsuits to obtain free medicines from the Brazilian Health System (SUS) is analyzed to characterize the supply of the requested drugs in two towns with different social and economic characteristics and different municipal ...
Silvana Nair Leite, Cristine Schaefer, Kelli Fittkau   +2 more
doaj   +1 more source

Referral Practices and Utilisation of Paediatric Oncology Physiotherapy Services in Ghana: A Cross‐Sectional Study

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Introduction Physical rehabilitation is highly recognised in improving the quality of life of cancer survivors through prehabilitation, sequelae management and palliative care, yet its integration into routine care in Ghana has not been characterised, leading to potential gaps in service access.
Dorothy Ekua Adjabu, Philip Junior Nyarko, Precious Madzimbe, Kofi Adesi Kyei, Tawagidu Mohammed, Sandra Banini   +5 more
wiley   +1 more source

Essential medicines in Tanzania : does the new delivery system improve supply and accountability? [PDF]

, 2013
Objective: Assess whether reform in the Tanzanian medicines delivery system from a central 'push' kit system to a decentralized 'pull' Integrated Logistics System (ILS) has improved medicines accountability.
Graham Reid, Inez Mikkelsen-Lopez, Harun Kasale, de Savigny, Don, Peter Cowley, Reid, Graham, Kasale, Harun, Don de Savigny, Mbuya, Conrad, Conrad Mbuya, Mikkelsen-Lopez, Inez, Cowley, Peter   +11 more
core   +2 more sources

Pediatric Mediastinal Gray Zone Lymphoma With Germline TET2 Heterozygous Variant

Pediatric Blood &Cancer, EarlyView.
Matthew R. Schuelke, Julia Wang, Haley Newman, Evelyn Kurpiewski, Anne Reilly, Susan R. Rheingold, Gerald Wertheim, Moe Takeda, Daniel J. Zheng, Kaitlin Devine   +9 more
wiley   +1 more source

Beyond the Document: A Single‐Center Qualitative Study of Survivorship Care Plan Barriers and Opportunities Across Pediatric Oncology Stakeholders

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Survivorship care plans (SCPs) summarize cancer treatment and guide risk‐based follow‐up for cancer survivors, yet remain difficult to create, share, and use. Stakeholder perspectives are needed to inform usable approaches.
Molly S. Talman, Emma Fleisher, Megan E. Salwei, Debra Friedman, Laurie Novak   +4 more
wiley   +1 more source

A systems approach to understanding mechanisms underlying immunisation barriers: a participatory design study in Tanzania

BMJ Global Health
Introduction The underlying causes of supply-side and demand-side challenges in immunisation are poorly understood, leading to symptomatic solutions. This study engaged stakeholders to develop model-based tools for understanding underlying mechanisms ...
Bruno F Sunguya, George Msema Bwire, Catherine Decouttere, Nico Vandaele, David T Myemba, Beatrice G Aiko, Leonor Guariguata   +6 more
doaj   +1 more source

Therapeutic Apheresis in Nigeria: A Multi‐Center Summary of Abstracts From the Inaugural Nigerian Society for Apheresis Scientific Meeting

Therapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Background Therapeutic apheresis (TA) is an established treatment modality for hematologic, neurologic, and immunologic disorders, yet access remains severely limited in sub‐Saharan Africa. Donor apheresis, including platelet apheresis collection from healthy donors, represents an important complementary modality supporting blood product ...
Nosa Bazuaye, Chimezie Okwuonu, Evelyn Idam, Folasade Adelekan‐Popoola, Shakirat Gold‐Olufadi, Olufunto Olufela Kalejaiye, Abdullateef Ogala, Zinnah Aloziem, Blossom Amamchukwu, Patience Elimia, Mkpoikanabasi Obot‐Obot, Henry Mbakwe, Praises Maduagwuna, Olatunji Akinrodoye, Chiamaka Anyanwu, Benjamin Anyanwu, Adedamola Akinsiku, Oluwatoyin A. Akinsiku, Muzamil O. Hassan, Fatiu A. Arogundade, Olalekan E. Ojo, Homayemem Weli, Jesupelumi Adenihun, Aderemi Adelaja, Ebun Bamgboye, Olalekan Olatise, Ade E. Faponle, Ayoola Odeyemi, Michael Muoka, Stephen Asaolu, Qudrat Busari, Blessing Dawudu, Michael Naiyeju, Rasheed A. Balogun   +33 more
wiley   +1 more source

Children's Medicines in Tanzania: A National Survey of Administration Practices and Preferences. [PDF]

, 2013
The dearth of age-appropriate formulations of many medicines for children poses a major challenge to pediatric therapeutic practice, adherence, and health care delivery worldwide.
Gary J Noel, Kisenge, R., Adams, Lisa V, Spielberg, S.P., Timothy Lahey (320330), Stephen P. Spielberg (385949), Cameron T Nutt, Mmbaga, Elia John, Sienna R Craig, Rodrick Kisenge (385947), Naburi, Helga, Gary J. Noel (385948), Noel, G.J., Nutt, Cameron T, Lahey, Timothy, Spielberg, Stephen P, Mmbaga, E.J., Adams, L .V., Elia John Mmbaga (313898), Craig, S.R., Spielberg Stephen P., Craig, Sienna R, Naburi Helga, Nutt Cameron T., Naburi, H., Sienna R. Craig (385944), Kisenge Rodrick, Timothy Lahey, Helga Naburi (385945), Noel Gary J., Craig Sienna R., Adams Lisa V., Lisa V Adams, Stephen P Spielberg, Noel, Gary J, Lisa V. Adams (385943), Mmbaga Elia John, Lahey, T., Rodrick Kisenge, Lahey Timothy, Nutt, C.T., Helga Naburi, Elia John Mmbaga, Kisenge, Rodrick, Cameron T. Nutt (385946)   +44 more
core   +2 more sources

Trading Away Access to Medicines: How the European Union's trade agenda has taken a wrong turn [PDF]

, 2009
Access to medicines poses a critical challenge in developing countries, largely because prices are high, and new or adapted medicines and vaccine to address diseases of the developing world are lacking.
Malpani, Rohit, Bloemen, Sophie
core   +1 more source